Arbutus Biopharma (NASDAQ:ABUS) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Arbutus Biopharma beat estimated earnings by 21.05%, reporting an EPS of $-0.15 versus an estimate of $-0.19.
Revenue was up $820.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 10.31% drop in the share price the next day.
Here's a look at Arbutus Biopharma's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.24 | -0.22 | -0.23 | -0.22 |
| EPS Actual | -0.24 | -0.23 | -0.21 | -0.23 |
| Revenue Estimate | 2.38M | 2.12M | 3.31M | 1.96M |
| Revenue Actual | 3.34M | 2.33M | 2.11M | 2.39M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
